GenSight Biologics S.A.
GSGTF
$0.19
-$0.05-20.79%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.95M | -2.96M | -3.95M | -3.67M | -4.35M |
| Total Depreciation and Amortization | 170.50K | 171.30K | 97.60K | 90.50K | 259.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 736.30K | 739.50K | 80.60K | 74.70K | 227.10K |
| Change in Net Operating Assets | -1.86M | -1.87M | 2.38M | 2.21M | 878.90K |
| Cash from Operations | -3.91M | -3.92M | -1.40M | -1.29M | -2.98M |
| Capital Expenditure | -2.30K | -2.30K | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 137.90K | 138.50K | -30.10K | -27.90K | 2.70K |
| Cash from Investing | 135.60K | 136.20K | -30.10K | -27.90K | 2.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -450.00K | -450.00K | -177.00K | -177.00K | -1.24M |
| Issuance of Common Stock | 2.73M | 2.73M | 362.00K | 362.00K | 2.51M |
| Repurchase of Common Stock | -- | -- | -- | -- | -2.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.04M | 2.04M | -29.50K | -29.50K | -559.50K |
| Cash from Financing | 5.02M | 5.04M | 176.50K | 163.60K | 749.90K |
| Foreign Exchange rate Adjustments | -1.70K | -1.80K | 4.50K | 4.20K | -158.30K |
| Miscellaneous Cash Flow Adjustments | 600.00 | 600.00 | -600.00 | -500.00 | 500.00 |
| Net Change in Cash | 1.25M | 1.25M | -1.25M | -1.15M | -2.39M |